Congenital slow channel myasthenic syndrome responding to fluoxetine treatment

被引：0
|
作者：
Peyer, A. -K.
Abicht, A.
Sinnreich, M.
Fischer, D.
机构：
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] Med Genet Zentrum, Munich, Germany
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P521
引用
收藏
页码：S170 / S171
页数：2
相关论文
共 50 条
  • [21] AChR channel blockade by quinidine sulfate reduces channel open duration in the slow-channel congenital myasthenic syndrome
    Fukudome, T
    Ohno, K
    Brengman, JM
    Engel, AG
    MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION, 1998, 841 : 199 - 202
  • [22] Phenotypic heterogeneity in a large Thai slow-channel congenital myasthenic syndrome kinship: Correction
    Witoonpanich, R.
    Pulkes, T.
    Dejthevaporn, C.
    Witoonpanich, P.
    Yodnopklao, P.
    Wetchaphanphesat, S.
    Brengman, J.
    Engel, A. G.
    NEUROMUSCULAR DISORDERS, 2012, 22 (05) : 478 - 478
  • [23] Adult-onset vocal cord paralysis in slow-channel congenital myasthenic syndrome
    Nakamura, Haruko
    Komiya, Hiroyasu
    Uematsu, Eri
    Nakae, Yoshiharu
    Tanaka, Kenichi
    Kunii, Misako
    Tada, Mikiko
    Joki, Hideto
    Koyano, Shigeru
    Matsumoto, Naomichi
    Doi, Hiroshi
    Takeuchi, Hideyuki
    Tanaka, Fumiaki
    NEUROLOGY-CLINICAL PRACTICE, 2019, 9 (05) : E45 - E47
  • [24] Diagnosis and treatment of congenital myasthenic syndrome
    Sieb, JP
    Hans, M
    Swandulla, D
    Marquard, K
    Steinlein, OK
    MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (05) : 453 - +
  • [25] Clinical and neurophysiological response to ephedrine in a patient affected with slow-channel congenital myasthenic syndrome
    Eiris-Punal, Jesus
    Fuentes-Pita, Patricia
    Gomez-Lado, Carmen
    Perez-Gay, Laura
    Lopez-Vazquez, Ana
    Quintas-Rey, Rita
    Barros-Angueira, Francisco
    Pardo, Julio
    REVISTA DE NEUROLOGIA, 2020, 71 (06) : 221 - 224
  • [26] Ephedrine in the treatment of congenital myasthenic syndrome
    Felice, KJ
    Relva, GM
    MUSCLE & NERVE, 1996, 19 (06) : 799 - 800
  • [27] Successful treatment with fluoxetine in a patient affected by congenital mysathenia slow cannel syndrome
    Colomer, J
    Vernet, A
    Müller, JS
    Nascimiento, A
    Lochmüller, H
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 737 - 737
  • [28] Variable phenotype in a fast channel congenital myasthenic syndrome
    Fitzpatrick, A. S.
    McConville, J. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 152 - 153
  • [29] A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment
    Webster, R. G.
    Cossins, J.
    Lashley, D.
    Maxwell, S.
    Liu, W. W.
    Wickens, J. R.
    Martinez-Martinez, P.
    de Baets, M.
    Beeson, D.
    EXPERIMENTAL NEUROLOGY, 2013, 248 : 286 - 298
  • [30] Mutations in the muscle acetylcholine receptor alpha subunit gene in slow-channel congenital myasthenic syndrome
    Beeson, D
    Newland, C
    Croxen, R
    Vincent, A
    NewsomDavis, J
    ANNALS OF NEUROLOGY, 1996, 40 (03) : 487 - 488
12345